Legend Biotech Corporation company logo
Legend Biotech Corporation logo

Legend Biotech Corporation (LEGN) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$1.12B$186.32M-14.23%

Summary

Current Value
As of today, LEGN annual cash & cash equivalents is $1.12B, down -14.23% on
Historical Performance
LEGN annual cash & cash equivalents is up +27.03% over the past 3 years, and up +605.34% over the past 5 years
All-Time High Comparison
LEGN annual cash & cash equivalents is currently -14.23% below its historical high of $1.31B set on
3-Year Low Comparison
LEGN annual cash & cash equivalents is +9.33% above its 3-year low of $1.03B reached on an earlier date
Sector Comparison
LEGN annual cash & cash equivalents is higher than 94.15% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

LEGN Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$1.12B-14.2%+27.0%+605.3%+10000.0%
Quarterly Cash & Cash Equivalents$992.66M-18.2%+72.2%
Price$23.60-28.0%-49.4%-20.2%
Annual Current Assets$1.28B-14.3%+35.2%+519.9%+456.1%
Annual Total Liabilities$623.45M+5.7%+77.3%+51.9%+175.2%
Annual Working Capital$1.01B-21.5%+39.6%+1168.3%+462.9%
Annual Net Income-$177.11M+65.8%+56.1%-33.2%-1991.2%

Cash and Cash Equivalents Highs

LEGN Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$1.31B-14.2%
5Y$1.31B-14.2%
All$1.31B-14.2%

Cash and Cash Equivalents Lows

LEGN Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$1.03BN/A+9.3%
5Y$506.07MN/A+121.9%
All$2.12M>+9999.0%

Cash and Cash Equivalents History

YearValueChange
$1.12B-14.2%
$1.31B+27.5%
$1.03B+16.2%
$883.84M+74.6%
YearValueChange
$506.07M+217.9%
$159.18M-26.5%
$216.44M>+9,900.0%
$2.12M-

FAQ

  • What is the current annual cash & cash equivalents of LEGN?

    As of today, LEGN annual cash & cash equivalents is $1.12B

  • What is 1-year change in LEGN annual cash & cash equivalents?

    LEGN annual cash & cash equivalents is down -14.23% year-over-year

  • What is 3-year change in LEGN annual cash & cash equivalents?

    LEGN annual cash & cash equivalents is up +27.03% over the past 3 years

  • How far is LEGN annual cash & cash equivalents from its all-time high?

    LEGN annual cash & cash equivalents is currently -14.23% below its historical high of $1.31B set on December 31, 2023

  • How does LEGN annual cash & cash equivalents rank versus sector peers?

    LEGN annual cash & cash equivalents is higher than 94.15% of companies in Healthcare sector

  • When is LEGN next annual earnings release?

    The next annual earnings release for LEGN is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. LEGN Official Website www.legendbiotech.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1801198/000180119825000031/0001801198-25-000031-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1801198/000180119825000012/0001801198-25-000012-index.htm
  4. LEGN Profile on Yahoo Finance finance.yahoo.com/quote/LEGN
  5. LEGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/legn